These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8836295)

  • 1. Potential doubling time and tumour doubling time in meningiomas and neurinomas.
    Nakasu S; Nakasu Y; Nakajima M; Yokoyama M; Matsuda M; Handa J
    Acta Neurochir (Wien); 1996; 138(6):763-70. PubMed ID: 8836295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
    Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
    Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIB-1 staining index of pediatric meningiomas.
    Sandberg DI; Edgar MA; Resch L; Rutka JT; Becker LE; Souweidane MM
    Neurosurgery; 2001 Mar; 48(3):590-5; discussion 595-7. PubMed ID: 11270550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of cell kinetic parameters in meningiomas.
    Nakagawa Y; Sugawa N; Ueda S; Suzuki K; Vignutelli A; Perentes E
    Neurol Med Chir (Tokyo); 1997 Jan; 37(1):12-7. PubMed ID: 9046799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
    Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
    Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferating cell nuclear antigen (PCNA) immunostaining as an alternative to bromodeoxyuridine (BrdU) immunostaining for brain tumours in paraffin embedded sections.
    Sasaki A; Naganuma H; Kimura R; Isoe S; Nakano S; Nukui H; Suzuki K; Kawaoi A
    Acta Neurochir (Wien); 1992; 117(3-4):178-81. PubMed ID: 1357920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index.
    Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
    Neurol Med Chir (Tokyo); 1995 May; 35(5):289-93. PubMed ID: 7623949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
    Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
    Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between MIB-1 staining index and the immunoreactivity of p53 protein in recurrent and non-recurrent meningiomas.
    Matsuno A; Nagashima T; Matsuura R; Tanaka H; Hirakawa M; Murakami M; Tamura A; Kirino T
    Am J Clin Pathol; 1996 Dec; 106(6):776-81. PubMed ID: 8980354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods.
    Nakasu S; Li DH; Okabe H; Nakajima M; Matsuda M
    Am J Surg Pathol; 2001 Apr; 25(4):472-8. PubMed ID: 11257621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between connexin-43 expression and Ki67 in non-glial central nervous system tumors.
    Krigers A; Moser P; Fritsch H; Demetz M; Kerschbaumer J; Brawanski KR; Thomé C; Freyschlag CF
    Int J Biol Markers; 2023 Mar; 38(1):46-52. PubMed ID: 36726335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
    J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MIB-1 staining index and peritumoral brain edema of meningiomas.
    Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
    Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cell kinetics of human meningiomas and neurinomas--Ki-67 PAP stain].
    Shibata T; Burger PC; Kleihues P
    No Shinkei Geka; 1988 Jul; 16(8):939-44. PubMed ID: 3050583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas.
    Vankalakunti M; Vasishta RK; Das Radotra B; Khosla VK
    Neuropathology; 2007 Oct; 27(5):407-12. PubMed ID: 18018472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry.
    Nakaguchi H; Fujimaki T; Matsuno A; Matsuura R; Asai A; Suzuki I; Sasaki T; Kirino T
    Cancer; 1999 May; 85(10):2249-54. PubMed ID: 10326705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity and usefulness of anti-phosphohistone-H3 antibody immunostaining for counting mitotic figures in meningioma cases.
    Fukushima S; Terasaki M; Sakata K; Miyagi N; Kato S; Sugita Y; Shigemori M
    Brain Tumor Pathol; 2009; 26(2):51-7. PubMed ID: 19856215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningioma: proliferating potential and clinicoradiological features.
    Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
    Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An autopsy case of intracranial multiple meningiomas associated with extracranial multiple neurinomas].
    Watanabe M; Watanabe Z; Sasaki T; Yamao N; Tanji H; Kodama N; Sato Y; Honda T; Endo S
    No Shinkei Geka; 1984 Jul; 12(8):995-9. PubMed ID: 6435004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.